As the global economy mends, the 2021 growth of Chronic Myeloid Leukemia Treatment will have significant change from previous year. According to our (Publisher) latest study, the global Chronic Myeloid Leukemia Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Chronic Myeloid Leukemia Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Chronic Myeloid Leukemia Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Chronic Myeloid Leukemia Treatment market, reaching US$ million by the year 2028. As for the Europe Chronic Myeloid Leukemia Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Chronic Myeloid Leukemia Treatment players cover Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd., Novartis AG, and Bristol-Myers Squibb Company, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Myeloid Leukemia Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablet
Solution
Capsule
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd.
Novartis AG
Bristol-Myers Squibb Company
Pfizer Inc.
Takeda Pharmaceutical Company Limited
Innovent Biologics, Inc.
Viatris Inc. (Mylan N.V.)
Lupin
IL-YANG PHARM CO. LTD.
Million Health Pharmaceuticals
Celon Labs
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chronic Myeloid Leukemia Treatment Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Chronic Myeloid Leukemia Treatment by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Chronic Myeloid Leukemia Treatment by Country/Region, 2017, 2022 & 2028
2.2 Chronic Myeloid Leukemia Treatment Segment by Type
2.2.1 Tablet
2.2.2 Solution
2.2.3 Capsule
2.3 Chronic Myeloid Leukemia Treatment Sales by Type
2.3.1 Global Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)
2.3.2 Global Chronic Myeloid Leukemia Treatment Revenue and Market Share by Type (2017-2022)
2.3.3 Global Chronic Myeloid Leukemia Treatment Sale Price by Type (2017-2022)
2.4 Chronic Myeloid Leukemia Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Chronic Myeloid Leukemia Treatment Sales by Application
2.5.1 Global Chronic Myeloid Leukemia Treatment Sale Market Share by Application (2017-2022)
2.5.2 Global Chronic Myeloid Leukemia Treatment Revenue and Market Share by Application (2017-2022)
2.5.3 Global Chronic Myeloid Leukemia Treatment Sale Price by Application (2017-2022)
3 Global Chronic Myeloid Leukemia Treatment by Company
3.1 Global Chronic Myeloid Leukemia Treatment Breakdown Data by Company
3.1.1 Global Chronic Myeloid Leukemia Treatment Annual Sales by Company (2020-2022)
3.1.2 Global Chronic Myeloid Leukemia Treatment Sales Market Share by Company (2020-2022)
3.2 Global Chronic Myeloid Leukemia Treatment Annual Revenue by Company (2020-2022)
3.2.1 Global Chronic Myeloid Leukemia Treatment Revenue by Company (2020-2022)
3.2.2 Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Chronic Myeloid Leukemia Treatment Sale Price by Company
3.4 Key Manufacturers Chronic Myeloid Leukemia Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Myeloid Leukemia Treatment Product Location Distribution
3.4.2 Players Chronic Myeloid Leukemia Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Chronic Myeloid Leukemia Treatment by Geographic Region
4.1 World Historic Chronic Myeloid Leukemia Treatment Market Size by Geographic Region (2017-2022)
4.1.1 Global Chronic Myeloid Leukemia Treatment Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Chronic Myeloid Leukemia Treatment Annual Revenue by Geographic Region
4.2 World Historic Chronic Myeloid Leukemia Treatment Market Size by Country/Region (2017-2022)
4.2.1 Global Chronic Myeloid Leukemia Treatment Annual Sales by Country/Region (2017-2022)
4.2.2 Global Chronic Myeloid Leukemia Treatment Annual Revenue by Country/Region
4.3 Americas Chronic Myeloid Leukemia Treatment Sales Growth
4.4 APAC Chronic Myeloid Leukemia Treatment Sales Growth
4.5 Europe Chronic Myeloid Leukemia Treatment Sales Growth
4.6 Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Growth
5 Americas
5.1 Americas Chronic Myeloid Leukemia Treatment Sales by Country
5.1.1 Americas Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022)
5.1.2 Americas Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022)
5.2 Americas Chronic Myeloid Leukemia Treatment Sales by Type
5.3 Americas Chronic Myeloid Leukemia Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Myeloid Leukemia Treatment Sales by Region
6.1.1 APAC Chronic Myeloid Leukemia Treatment Sales by Region (2017-2022)
6.1.2 APAC Chronic Myeloid Leukemia Treatment Revenue by Region (2017-2022)
6.2 APAC Chronic Myeloid Leukemia Treatment Sales by Type
6.3 APAC Chronic Myeloid Leukemia Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Chronic Myeloid Leukemia Treatment by Country
7.1.1 Europe Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022)
7.1.2 Europe Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022)
7.2 Europe Chronic Myeloid Leukemia Treatment Sales by Type
7.3 Europe Chronic Myeloid Leukemia Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chronic Myeloid Leukemia Treatment by Country
8.1.1 Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022)
8.1.2 Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Type
8.3 Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Myeloid Leukemia Treatment
10.3 Manufacturing Process Analysis of Chronic Myeloid Leukemia Treatment
10.4 Industry Chain Structure of Chronic Myeloid Leukemia Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Myeloid Leukemia Treatment Distributors
11.3 Chronic Myeloid Leukemia Treatment Customer
12 World Forecast Review for Chronic Myeloid Leukemia Treatment by Geographic Region
12.1 Global Chronic Myeloid Leukemia Treatment Market Size Forecast by Region
12.1.1 Global Chronic Myeloid Leukemia Treatment Forecast by Region (2023-2028)
12.1.2 Global Chronic Myeloid Leukemia Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chronic Myeloid Leukemia Treatment Forecast by Type
12.7 Global Chronic Myeloid Leukemia Treatment Forecast by Application
13 Key Players Analysis
13.1 Teva Pharmaceutical Industries Ltd
13.1.1 Teva Pharmaceutical Industries Ltd Company Information
13.1.2 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Product Offered
13.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.1.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.2 F. Hoffmann-La Roche Ltd.
13.2.1 F. Hoffmann-La Roche Ltd. Company Information
13.2.2 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Product Offered
13.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Chronic Myeloid Leukemia Treatment Product Offered
13.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Bristol-Myers Squibb Company
13.4.1 Bristol-Myers Squibb Company Company Information
13.4.2 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Product Offered
13.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bristol-Myers Squibb Company Main Business Overview
13.4.5 Bristol-Myers Squibb Company Latest Developments
13.5 Pfizer Inc.
13.5.1 Pfizer Inc. Company Information
13.5.2 Pfizer Inc. Chronic Myeloid Leukemia Treatment Product Offered
13.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Inc. Main Business Overview
13.5.5 Pfizer Inc. Latest Developments
13.6 Takeda Pharmaceutical Company Limited
13.6.1 Takeda Pharmaceutical Company Limited Company Information
13.6.2 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Product Offered
13.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.6.5 Takeda Pharmaceutical Company Limited Latest Developments
13.7 Innovent Biologics, Inc.
13.7.1 Innovent Biologics, Inc. Company Information
13.7.2 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Product Offered
13.7.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Innovent Biologics, Inc. Main Business Overview
13.7.5 Innovent Biologics, Inc. Latest Developments
13.8 Viatris Inc. (Mylan N.V.)
13.8.1 Viatris Inc. (Mylan N.V.) Company Information
13.8.2 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Product Offered
13.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Viatris Inc. (Mylan N.V.) Main Business Overview
13.8.5 Viatris Inc. (Mylan N.V.) Latest Developments
13.9 Lupin
13.9.1 Lupin Company Information
13.9.2 Lupin Chronic Myeloid Leukemia Treatment Product Offered
13.9.3 Lupin Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Lupin Main Business Overview
13.9.5 Lupin Latest Developments
13.10 IL-YANG PHARM CO. LTD.
13.10.1 IL-YANG PHARM CO. LTD. Company Information
13.10.2 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Product Offered
13.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 IL-YANG PHARM CO. LTD. Main Business Overview
13.10.5 IL-YANG PHARM CO. LTD. Latest Developments
13.11 Million Health Pharmaceuticals
13.11.1 Million Health Pharmaceuticals Company Information
13.11.2 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Product Offered
13.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Million Health Pharmaceuticals Main Business Overview
13.11.5 Million Health Pharmaceuticals Latest Developments
13.12 Celon Labs
13.12.1 Celon Labs Company Information
13.12.2 Celon Labs Chronic Myeloid Leukemia Treatment Product Offered
13.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Celon Labs Main Business Overview
13.12.5 Celon Labs Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Chronic Myeloid Leukemia Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Chronic Myeloid Leukemia Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Solution
Table 5. Major Players of Capsule
Table 6. Global Chronic Myeloid Leukemia Treatment Sales by Type (2017-2022) & (K Units)
Table 7. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)
Table 8. Global Chronic Myeloid Leukemia Treatment Revenue by Type (2017-2022) & ($ million)
Table 9. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Type (2017-2022)
Table 10. Global Chronic Myeloid Leukemia Treatment Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Chronic Myeloid Leukemia Treatment Sales by Application (2017-2022) & (K Units)
Table 12. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)
Table 13. Global Chronic Myeloid Leukemia Treatment Revenue by Application (2017-2022)
Table 14. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Application (2017-2022)
Table 15. Global Chronic Myeloid Leukemia Treatment Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Chronic Myeloid Leukemia Treatment Sales by Company (2020-2022) & (K Units)
Table 17. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Company (2020-2022)
Table 18. Global Chronic Myeloid Leukemia Treatment Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Company (2020-2022)
Table 20. Global Chronic Myeloid Leukemia Treatment Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Chronic Myeloid Leukemia Treatment Producing Area Distribution and Sales Area
Table 22. Players Chronic Myeloid Leukemia Treatment Products Offered
Table 23. Chronic Myeloid Leukemia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Chronic Myeloid Leukemia Treatment Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Chronic Myeloid Leukemia Treatment Sales Market Share Geographic Region (2017-2022)
Table 28. Global Chronic Myeloid Leukemia Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Chronic Myeloid Leukemia Treatment Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Country/Region (2017-2022)
Table 32. Global Chronic Myeloid Leukemia Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022) & (K Units)
Table 35. Americas Chronic Myeloid Leukemia Treatment Sales Market Share by Country (2017-2022)
Table 36. Americas Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Chronic Myeloid Leukemia Treatment Revenue Market Share by Country (2017-2022)
Table 38. Americas Chronic Myeloid Leukemia Treatment Sales by Type (2017-2022) & (K Units)
Table 39. Americas Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)
Table 40. Americas Chronic Myeloid Leukemia Treatment Sales by Application (2017-2022) & (K Units)
Table 41. Americas Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)
Table 42. APAC Chronic Myeloid Leukemia Treatment Sales by Region (2017-2022) & (K Units)
Table 43. APAC Chronic Myeloid Leukemia Treatment Sales Market Share by Region (2017-2022)
Table 44. APAC Chronic Myeloid Leukemia Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Chronic Myeloid Leukemia Treatment Revenue Market Share by Region (2017-2022)
Table 46. APAC Chronic Myeloid Leukemia Treatment Sales by Type (2017-2022) & (K Units)
Table 47. APAC Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)
Table 48. APAC Chronic Myeloid Leukemia Treatment Sales by Application (2017-2022) & (K Units)
Table 49. APAC Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)
Table 50. Europe Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022) & (K Units)
Table 51. Europe Chronic Myeloid Leukemia Treatment Sales Market Share by Country (2017-2022)
Table 52. Europe Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Chronic Myeloid Leukemia Treatment Revenue Market Share by Country (2017-2022)
Table 54. Europe Chronic Myeloid Leukemia Treatment Sales by Type (2017-2022) & (K Units)
Table 55. Europe Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)
Table 56. Europe Chronic Myeloid Leukemia Treatment Sales by Application (2017-2022) & (K Units)
Table 57. Europe Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Chronic Myeloid Leukemia Treatment
Table 67. Key Market Challenges & Risks of Chronic Myeloid Leukemia Treatment
Table 68. Key Industry Trends of Chronic Myeloid Leukemia Treatment
Table 69. Chronic Myeloid Leukemia Treatment Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Chronic Myeloid Leukemia Treatment Distributors List
Table 72. Chronic Myeloid Leukemia Treatment Customer List
Table 73. Global Chronic Myeloid Leukemia Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Chronic Myeloid Leukemia Treatment Sales Market Forecast by Region
Table 75. Global Chronic Myeloid Leukemia Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Chronic Myeloid Leukemia Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Chronic Myeloid Leukemia Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Chronic Myeloid Leukemia Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Chronic Myeloid Leukemia Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Chronic Myeloid Leukemia Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Chronic Myeloid Leukemia Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Chronic Myeloid Leukemia Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Chronic Myeloid Leukemia Treatment Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Chronic Myeloid Leukemia Treatment Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Chronic Myeloid Leukemia Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Chronic Myeloid Leukemia Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Chronic Myeloid Leukemia Treatment Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Chronic Myeloid Leukemia Treatment Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Chronic Myeloid Leukemia Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Chronic Myeloid Leukemia Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 93. Teva Pharmaceutical Industries Ltd Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Product Offered
Table 95. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Teva Pharmaceutical Industries Ltd Main Business
Table 97. Teva Pharmaceutical Industries Ltd Latest Developments
Table 98. F. Hoffmann-La Roche Ltd. Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Product Offered
Table 100. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. F. Hoffmann-La Roche Ltd. Main Business
Table 102. F. Hoffmann-La Roche Ltd. Latest Developments
Table 103. Novartis AG Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis AG Chronic Myeloid Leukemia Treatment Product Offered
Table 105. Novartis AG Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Novartis AG Main Business
Table 107. Novartis AG Latest Developments
Table 108. Bristol-Myers Squibb Company Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Product Offered
Table 110. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Bristol-Myers Squibb Company Main Business
Table 112. Bristol-Myers Squibb Company Latest Developments
Table 113. Pfizer Inc. Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Inc. Chronic Myeloid Leukemia Treatment Product Offered
Table 115. Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Pfizer Inc. Main Business
Table 117. Pfizer Inc. Latest Developments
Table 118. Takeda Pharmaceutical Company Limited Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Product Offered
Table 120. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Takeda Pharmaceutical Company Limited Main Business
Table 122. Takeda Pharmaceutical Company Limited Latest Developments
Table 123. Innovent Biologics, Inc. Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Product Offered
Table 125. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Innovent Biologics, Inc. Main Business
Table 127. Innovent Biologics, Inc. Latest Developments
Table 128. Viatris Inc. (Mylan N.V.) Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Product Offered
Table 130. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Viatris Inc. (Mylan N.V.) Main Business
Table 132. Viatris Inc. (Mylan N.V.) Latest Developments
Table 133. Lupin Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 134. Lupin Chronic Myeloid Leukemia Treatment Product Offered
Table 135. Lupin Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Lupin Main Business
Table 137. Lupin Latest Developments
Table 138. IL-YANG PHARM CO. LTD. Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 139. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Product Offered
Table 140. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. IL-YANG PHARM CO. LTD. Main Business
Table 142. IL-YANG PHARM CO. LTD. Latest Developments
Table 143. Million Health Pharmaceuticals Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 144. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Product Offered
Table 145. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Million Health Pharmaceuticals Main Business
Table 147. Million Health Pharmaceuticals Latest Developments
Table 148. Celon Labs Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 149. Celon Labs Chronic Myeloid Leukemia Treatment Product Offered
Table 150. Celon Labs Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Celon Labs Main Business
Table 152. Celon Labs Latest Developments
List of Figures
Figure 1. Picture of Chronic Myeloid Leukemia Treatment
Figure 2. Chronic Myeloid Leukemia Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Myeloid Leukemia Treatment Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Chronic Myeloid Leukemia Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Chronic Myeloid Leukemia Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Solution
Figure 11. Product Picture of Capsule
Figure 12. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Type in 2021
Figure 13. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Type (2017-2022)
Figure 14. Chronic Myeloid Leukemia Treatment Consumed in Hospital Pharmacies
Figure 15. Global Chronic Myeloid Leukemia Treatment Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 16. Chronic Myeloid Leukemia Treatment Consumed in Retail Pharmacies
Figure 17. Global Chronic Myeloid Leukemia Treatment Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 18. Chronic Myeloid Leukemia Treatment Consumed in Online Pharmacies
Figure 19. Global Chronic Myeloid Leukemia Treatment Market: Online Pharmacies (2017-2022) & (K Units)
Figure 20. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)
Figure 21. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Application in 2021
Figure 22. Chronic Myeloid Leukemia Treatment Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Company in 2021
Figure 24. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Geographic Region in 2021
Figure 26. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Region (2017-2022)
Figure 27. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Country/Region in 2021
Figure 28. Americas Chronic Myeloid Leukemia Treatment Sales 2017-2022 (K Units)
Figure 29. Americas Chronic Myeloid Leukemia Treatment Revenue 2017-2022 ($ Millions)
Figure 30. APAC Chronic Myeloid Leukemia Treatment Sales 2017-2022 (K Units)
Figure 31. APAC Chronic Myeloid Leukemia Treatment Revenue 2017-2022 ($ Millions)
Figure 32. Europe Chronic Myeloid Leukemia Treatment Sales 2017-2022 (K Units)
Figure 33. Europe Chronic Myeloid Leukemia Treatment Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue 2017-2022 ($ Millions)
Figure 36. Americas Chronic Myeloid Leukemia Treatment Sales Market Share by Country in 2021
Figure 37. Americas Chronic Myeloid Leukemia Treatment Revenue Market Share by Country in 2021
Figure 38. United States Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Chronic Myeloid Leukemia Treatment Sales Market Share by Region in 2021
Figure 43. APAC Chronic Myeloid Leukemia Treatment Revenue Market Share by Regions in 2021
Figure 44. China Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Chronic Myeloid Leukemia Treatment Sales Market Share by Country in 2021
Figure 51. Europe Chronic Myeloid Leukemia Treatment Revenue Market Share by Country in 2021
Figure 52. Germany Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue Market Share by Country in 2021
Figure 59. Egypt Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Chronic Myeloid Leukemia Treatment in 2021
Figure 65. Manufacturing Process Analysis of Chronic Myeloid Leukemia Treatment
Figure 66. Industry Chain Structure of Chronic Myeloid Leukemia Treatment
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles